Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Dividends Paid - Common (2017 - 2025)

Fortress Biotech (FBIO) has 9 years of Dividends Paid - Common data on record, last reported at $166000.0 in Q3 2025.

  • For Q3 2025, Dividends Paid - Common fell 5.68% year-over-year to $166000.0; the TTM value through Sep 2025 reached $4.0 million, up 462.99%, while the annual FY2024 figure was $4.0 million, 445.65% up from the prior year.
  • Dividends Paid - Common reached $166000.0 in Q3 2025 per FBIO's latest filing, roughly flat from $166000.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $3.5 million in Q4 2024 and bottomed at -$5.3 million in Q4 2022.
  • Average Dividends Paid - Common over 5 years is $259315.8, with a median of $185000.0 recorded in 2023.
  • Peak YoY movement for Dividends Paid - Common: tumbled 2920.86% in 2022, then surged 1837.78% in 2024.
  • A 5-year view of Dividends Paid - Common shows it stood at $187000.0 in 2021, then crashed by 2920.86% to -$5.3 million in 2022, then surged by 103.41% to $180000.0 in 2023, then soared by 1837.78% to $3.5 million in 2024, then crashed by 95.24% to $166000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Dividends Paid - Common were $166000.0 in Q3 2025, $166000.0 in Q2 2025, and $166000.0 in Q1 2025.